Skip to main content
Cy Stein, MD, Oncology, Duarte, CA

CySteinMDPhD

Oncology Duarte, CA

Professor, Medicine, Oncology; Molecular Pharmacology; Urology, Albert Einstein College of Medicine

Dr. Stein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Stein's full profile

Already have an account?

  • Office

    1500 E Duarte Rd
    City of Hope, Med Oncology Dept
    Duarte, CA 91010
    Phone+1 626-471-3890
    Fax+1 626-471-7322

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1985 - 1988
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1982 - 1985
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1982

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1984 - 2026
  • CA State Medical License
    CA State Medical License 2012 - 2021
  • MD State Medical License
    MD State Medical License 1985 - 1991
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2014
  • Top Doctors:LA Area Castle Connolly, 2013
  • America's Top Doctors for Cancer Castle Connolly, 2013
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • A Stress-Induced Response Complex (SIRC) Shuttles miRNAs, siRNAs, and Oligonucleotides to the Nucleus  
    Cy Stein, MD, Proceedings of the National Academy of Sciences

Press Mentions

  • The World's First Drug Made for Only One Patient
    The World's First Drug Made for Only One PatientOctober 11th, 2019
  • Learning from Suramin: A Case Study of NCI’s Much-Hyped Cancer Drug That Crashed and Burned—35 Years Ago
    Learning from Suramin: A Case Study of NCI’s Much-Hyped Cancer Drug That Crashed and Burned—35 Years AgoAugust 9th, 2019
  • Myovant’s Supposed Market Edge in Castrate-Sensitive Prostate Cancer Draws Reservations
    Myovant’s Supposed Market Edge in Castrate-Sensitive Prostate Cancer Draws ReservationsMarch 22nd, 2019
  • Join now to see all